Insider Transactions in Q1 2021 at Interpace Biosciences, Inc. (IDXG)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 10
2021
|
Thomas John Freeburg Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+49.02%
|
-
|
|
Mar 01
2021
|
Peter Kamin > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
25,840
+5.92%
|
$77,520
$3.08 P/Share
|
|
Mar 01
2021
|
Peter Kamin > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
16,360
+5.71%
|
$49,080
$3.08 P/Share
|
|
Feb 26
2021
|
Peter Kamin > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
26,104
+6.35%
|
$78,312
$3.17 P/Share
|
|
Feb 26
2021
|
Peter Kamin > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
14,946
+5.56%
|
$44,838
$3.17 P/Share
|
|
Jan 29
2021
|
Robert J. Gorman Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,438
+39.87%
|
$49,752
$4.02 P/Share
|